Wellington Partners
Edit

Wellington Partners

https://www.wellington-partners.com
Last activity: 25.03.2025
Active
Invests in categories: TechnologyMedtechDataHealthTechPlatformProductITAppServiceMusic
Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years.

We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million.

Providing funding is only one part of our business. After funding, the entrepreneurs we back have access to the advice and guidance of our complete team and our entire global network. Our investment professionals operate out of four offices, located in London, Munich, Zurich and Palo Alto. The pan-European and transatlantic makeup of our organisation enables us to support our portfolio in expanding globally.

To date, Wellington Partners has invested in more than 100 companies throughout Europe. We have been a part of great successes as well as dismal failures. In our view, success has always been the result of a great idea executed by a great team with strong leadership and commitment; plus an enormous amount of hard work and an ounce of luck, the good fortune to be in the right place at right time.
Likes
1.33K
Portfolio
91
Persons
8
Mentions
121
Location: Germany, Bavaria, Munich
Employees: 11-50
Founded date: 1998
Investment Type: Venture Capital
Investment Stage: Series A; Series C

Portfolio 91

DateNameWebsiteTotal RaisedLocation
16.03.2023Seamlessseamlesstx.com$12.5MGermany, S...
25.02.2021Creative B...creativeballoons.de$18.25MGermany, B...
28.01.2021SIRS Thera...sirs-therapeutics.com--
09.01.2021ONWARDonwd.com$266.8MNetherland...
22.12.2020Minervax A...minervax.com$196.51MDenmark, C...
28.10.2020Sidekick H...sidekickhealth.com$76.5MSweden, Go...
07.05.2019Confo Ther...confotherapeutics.com$106.07MBelgium
26.11.2018Adrenomed ...adrenomed.com$55.23MGermany, B...
08.10.2018SphingoTecsphingotec.com$24.1MGermany, B...
03.05.2016Symetissymetis.com$25.93MUnited Sta...
Show more

Persons 8

DateFirst NameLast NameTitleLinkedInLocation
-OlenaIonkinaFinance Ma...-
-Dr.Johannes F...Partnerlinkedin.c...-
-Dr.Varun Gupt...Partnerlinkedin.c...-
-KaiWohlberedtAssociatelinkedin.c...-
-HélèneVERGERExecutive ...linkedin.c...-
-ErichSchlickGeneral Pa...linkedin.c...-
-Dr.Robert Bus...Analystlinkedin.c...-
-FrankBoehnkeGeneral Pa...linkedin.c...-

Mentions in press and media 121

DateTitleDescription
25.03.2025M&G Faces Stormy Seas Amid Outflows, While Amboss Sets Sail for Global ExpansionIn the world of finance and education, two companies are navigating turbulent waters. M&G, a prominent insurer and asset manager, is grappling with significant outflows, while Amboss, a medical education platform, is riding a wave of in...
25.03.2025Medical education company Amboss secures $260M for global expansionPhoto: Franziska & Tom Werner/Getty Images Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round. The round included new primary investors KIRKBI, M...
04.11.2024+++ Ride +++ bao +++ Aignostics +++ neoshare +++ Series-A +++Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Montag, 4. November) #STARTUPLAND: LEARN, CONNECT, GROW Kommt mit ins Startupland! Es erwartet Euch eine fas...
03.11.2024Aignostics: $34 Million (Series B) Raised To Turn Complex Pathology Data Into Transformative InsightsAignostics – a global AI company that turns complex multi-modal pathology data into transformative insights – announced that it has raised $34 million in Series B financing. This additional funding will be used for building new product offe...
29.10.2024Aignostics: Pioneering AI in Precision Medicine with $34 Million BoostAignostics, a Berlin-based artificial intelligence (AI) company, has secured $34 million in Series B funding. This significant investment is a testament to the growing confidence in AI's role in transforming healthcare. The funding round wa...
29.10.2024Berlin-based Aignostics secures €31.4 million Series B to enhance precision medicine with AIAignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised €31.4 million in Series B financing. This additional funding will be used to ...
29.10.2024Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AIInvestments will support new product offerings, US expansion, and development of pathology foundation models. Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insigh...
29.10.2024Aignostics Secures $34M to Advance AI-Powered Pathology and Precision MedicineWhat You Should Know: – Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with participation from Mayo Clinic and growth financing from HTGF, alongisde existing investors...
12.09.2024CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack TreatmentCorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa...
12.09.2024CorFlow Therapeutics: €44 Million (Series B) Raised For Advancing Drug Delivery Platform Related To Microvascular Obstruction In Heart Attack PatientsCorFlow Therapeutics AG announced that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes Partners with strong continued support from 415 Capital (CorFlow’s initial VC investor and largest shareholder). ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In